Figure 2.
Figure 2. iEMs incubated with aPL plasma (B, D) and plasma from a healthy donor (A, C) visualized with bright field microscopy. Aggregate formation seen after incubation with aPL plasma (B) is hardly seen with normal plasma (A); Agglutinate formation after addition of anti-hIgG/anti-hC3d (C, D) is amplified in aPL plasma (D) compared to normal plasma (C). Examples of aggregates are indicated with white arrows.

iEMs incubated with aPL plasma (B, D) and plasma from a healthy donor (A, C) visualized with bright field microscopy. Aggregate formation seen after incubation with aPL plasma (B) is hardly seen with normal plasma (A); Agglutinate formation after addition of anti-hIgG/anti-hC3d (C, D) is amplified in aPL plasma (D) compared to normal plasma (C). Examples of aggregates are indicated with white arrows.

Close Modal

or Create an Account

Close Modal
Close Modal